Author

Catigan A. Hedican

University of Wisconsin–MadisonORCID 0009-0005-6754-4461Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Immunology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Assay:flow cytometry· 1 Organism:human· 1 Organism:mouse· 1 Assay:proteomics· 1

Frequent Co-Authors

Rahul DasiD· 2 shared Amar M. YewareiD· 1 shared Andrea PennatiiD· 1 shared Andrea PennatiiD· 1 shared Jacques GalipeauiD· 1 shared Lisa Marie BarroilhetiD· 1 shared Manish S. PatankariD· 1 shared Sejal SharmaiD· 1 shared

Activity by Year

2026-2026 · peak 2/yr

Co-Author Collaboration Network

9 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

Rahul DasORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

ImmunologyScientific ReportsPeer-reviewedSep 2, 2026

A CD40-Targeted IL-21 Fusokine Enables Rapid Generation of Human IL-10⁺Granzyme B⁺ Regulatory B Cells

Andrea Pennati, Shala Yuan, Rahul Das…·Amar M. Yeware

This paper demonstrates that a CD40-targeted IL-21 fusion protein and TLR9 activation can induce a stable regulatory B cell phenotype in human B cells with high efficiency.

DOI 10.1038/s41598-026-69478-3

humanflow cytometry

𝕏 PostBluesky

ImmunologybioRxivPreprintMay 8, 2026

An autologous cell-based therapeutic vaccine expressing IL6/1 fusokine drives robust anti-tumor response against ovarian cancer.

Sejal Sharma, Rahul Das, Andrea Pennati…·Jacques Galipeau

This paper develops an IL6/1 fusokine that enhances T cell survival and anti-tumor response in a preclinical ovarian cancer model.

DOI 10.64898/2026.05.05.721149

mouseproteomics

𝕏 PostBluesky